Author Question: Describe the differences between provider --to--patient e--mail and E--visits. What will be an ... (Read 28 times)

darbym82

  • Hero Member
  • *****
  • Posts: 570
Describe the differences between provider --to--patient e--mail and E--visits.
 
  What will be an ideal response?

Question 2

The difference between the assets and liabilities is the:
 
  A) net worth. B) liability. C) expenses. D) revenue. E) profit.



mjbamaung

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

An E--visit is secure, but E--mail is not.

The E--visit gathers symptom and HPI information and creates a documented medical exam. E-- mail is free text.

When it is integrated with the EHR , the E--visit becomes part of the patient's chart, just like any other visit. It would be difficult for a provider to save an e --mail exchange as part of a patient's EHR record.

E--visits are reimbursed as a legitimate E&M visit; e--mail exchanges are not.

E--mail is directed at a particular individual and therefore is not likely to be accessible by another provider; E--visits can be directed to the doctor on call, thus allowing practicing partners to share being on call.

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

A recent study has found that following a diet rich in berries may slow down the aging process of the brain. This diet apparently helps to keep dopamine levels much higher than are seen in normal individuals who do not eat berries as a regular part of their diet as they enter their later years.

Did you know?

Eating food that has been cooked with poppy seeds may cause you to fail a drug screening test, because the seeds contain enough opiate alkaloids to register as a positive.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

For a complete list of videos, visit our video library